Aptevo Therapeutics Inc. (APVO) SEC Filings — 2026
2 SEC filings for Aptevo Therapeutics Inc. (APVO) in 2026.
Filings
- Aptevo's Mipletamig Shows Strong Efficacy, Safety in Frontline AML Trial — 10-K · Mar 26, 2026
- Aptevo Therapeutics Files 8-K on Financials — 8-K · Mar 26, 2026